| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6822773 | Schizophrenia Research | 2016 | 7 Pages |
Abstract
Our findings highlight that certain patient groups are at an increased risk for long-term APP initiation. Identifying these groups earlier in their treatment could encourage clinicians to employ a broader range of interventions in addition to pharmacotherapy to reduce the risk of APP prescribing.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Giouliana Kadra, Robert Stewart, Hitesh Shetty, Johnny Downs, James H. MacCabe, David Taylor, Richard D. Hayes,